---
document_datetime: 2025-12-02 05:40:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/memantine-lek.html
document_name: memantine-lek.html
version: success
processing_time: 0.105391
conversion_datetime: 2025-12-24 20:37:49.425593
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Memantine LEK

[RSS](/en/individual-human-medicine.xml/65805)

##### Withdrawn

This medicine's authorisation has been withdrawn

memantine Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 6 September 2024, the European Commission withdrew the marketing authorisation for Memantine LEK (memantine hydrochloride) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Pharmathen S.A., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Memantine LEK was granted marketing authorisation in the EU on 22 April 2013 for the treatment of Alzheimer's disease. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2018.

Memantine LEK is a generic medicine of Ebixa. There are other generic medicinal products of Ebixa authorised and marketed in the EU. The European Public Assessment Report (EPAR) for Memantine LEK is updated to indicate that the marketing authorisation is no longer valid.

Memantine LEK : EPAR - Summary for the public

Reference Number: EMA/136423/2013

English (EN) (145.82 KB - PDF)

**First published:** 29/04/2013

**Last updated:** 23/10/2024

[View](/en/documents/overview/memantine-lek-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-16)

български (BG) (250.47 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/bg/documents/overview/memantine-lek-epar-summary-public_bg.pdf)

español (ES) (175.9 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/es/documents/overview/memantine-lek-epar-summary-public_es.pdf)

čeština (CS) (216.59 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/cs/documents/overview/memantine-lek-epar-summary-public_cs.pdf)

dansk (DA) (169.03 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/da/documents/overview/memantine-lek-epar-summary-public_da.pdf)

Deutsch (DE) (153.9 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/de/documents/overview/memantine-lek-epar-summary-public_de.pdf)

eesti keel (ET) (146.26 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/et/documents/overview/memantine-lek-epar-summary-public_et.pdf)

ελληνικά (EL) (220.2 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/el/documents/overview/memantine-lek-epar-summary-public_el.pdf)

français (FR) (174.83 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/fr/documents/overview/memantine-lek-epar-summary-public_fr.pdf)

italiano (IT) (172 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/it/documents/overview/memantine-lek-epar-summary-public_it.pdf)

latviešu valoda (LV) (183.84 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/lv/documents/overview/memantine-lek-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (208.13 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/lt/documents/overview/memantine-lek-epar-summary-public_lt.pdf)

magyar (HU) (183.84 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/hu/documents/overview/memantine-lek-epar-summary-public_hu.pdf)

Malti (MT) (218.95 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/mt/documents/overview/memantine-lek-epar-summary-public_mt.pdf)

Nederlands (NL) (179.87 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/nl/documents/overview/memantine-lek-epar-summary-public_nl.pdf)

polski (PL) (189.51 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/pl/documents/overview/memantine-lek-epar-summary-public_pl.pdf)

português (PT) (172.9 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/pt/documents/overview/memantine-lek-epar-summary-public_pt.pdf)

română (RO) (190.51 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/ro/documents/overview/memantine-lek-epar-summary-public_ro.pdf)

slovenčina (SK) (209.29 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/sk/documents/overview/memantine-lek-epar-summary-public_sk.pdf)

slovenščina (SL) (202.38 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/sl/documents/overview/memantine-lek-epar-summary-public_sl.pdf)

Suomi (FI) (168.03 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/fi/documents/overview/memantine-lek-epar-summary-public_fi.pdf)

svenska (SV) (168.67 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/sv/documents/overview/memantine-lek-epar-summary-public_sv.pdf)

## Product information

Memantine LEK : EPAR - Product Information

English (EN) (1.59 MB - PDF)

**First published:** 29/04/2013

**Last updated:** 23/10/2024

[View](/en/documents/product-information/memantine-lek-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-550)

български (BG) (1.82 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/bg/documents/product-information/memantine-lek-epar-product-information_bg.pdf)

español (ES) (1.62 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/es/documents/product-information/memantine-lek-epar-product-information_es.pdf)

čeština (CS) (1.84 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/cs/documents/product-information/memantine-lek-epar-product-information_cs.pdf)

dansk (DA) (1.6 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/da/documents/product-information/memantine-lek-epar-product-information_da.pdf)

Deutsch (DE) (1.57 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/de/documents/product-information/memantine-lek-epar-product-information_de.pdf)

eesti keel (ET) (1.61 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/et/documents/product-information/memantine-lek-epar-product-information_et.pdf)

ελληνικά (EL) (2.07 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/el/documents/product-information/memantine-lek-epar-product-information_el.pdf)

français (FR) (1.7 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/fr/documents/product-information/memantine-lek-epar-product-information_fr.pdf)

hrvatski (HR) (1.67 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/hr/documents/product-information/memantine-lek-epar-product-information_hr.pdf)

íslenska (IS) (1.63 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/is/documents/product-information/memantine-lek-epar-product-information_is.pdf)

italiano (IT) (1.64 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/it/documents/product-information/memantine-lek-epar-product-information_it.pdf)

latviešu valoda (LV) (1.62 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/lv/documents/product-information/memantine-lek-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.58 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/lt/documents/product-information/memantine-lek-epar-product-information_lt.pdf)

magyar (HU) (1.68 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/hu/documents/product-information/memantine-lek-epar-product-information_hu.pdf)

Malti (MT) (1.91 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/mt/documents/product-information/memantine-lek-epar-product-information_mt.pdf)

Nederlands (NL) (1.57 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/nl/documents/product-information/memantine-lek-epar-product-information_nl.pdf)

norsk (NO) (1.5 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/no/documents/product-information/memantine-lek-epar-product-information_no.pdf)

polski (PL) (1.63 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/pl/documents/product-information/memantine-lek-epar-product-information_pl.pdf)

português (PT) (1.53 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/pt/documents/product-information/memantine-lek-epar-product-information_pt.pdf)

română (RO) (1.47 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/ro/documents/product-information/memantine-lek-epar-product-information_ro.pdf)

slovenčina (SK) (1.74 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/sk/documents/product-information/memantine-lek-epar-product-information_sk.pdf)

slovenščina (SL) (1.6 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/sl/documents/product-information/memantine-lek-epar-product-information_sl.pdf)

Suomi (FI) (1.59 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/fi/documents/product-information/memantine-lek-epar-product-information_fi.pdf)

svenska (SV) (1.51 MB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/sv/documents/product-information/memantine-lek-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0010 20/10/2020

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Memantine LEK : EPAR - All Authorised presentations

English (EN) (42.11 KB - PDF)

**First published:** 29/04/2013

**Last updated:** 23/10/2024

[View](/en/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-68)

български (BG) (90.25 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/bg/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_bg.pdf)

español (ES) (49.93 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/es/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_es.pdf)

čeština (CS) (58.66 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/cs/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (43.47 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/da/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (42.66 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/de/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (48.76 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/et/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (98.63 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/el/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_el.pdf)

français (FR) (48.89 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/fr/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (98.72 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/hr/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (44.81 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/is/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_is.pdf)

italiano (IT) (44.59 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/it/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (79.26 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/lv/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (82.6 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/lt/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (78.12 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/hu/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (77.59 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/mt/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (43.81 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/nl/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (42.48 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/no/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_no.pdf)

polski (PL) (57.26 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/pl/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_pl.pdf)

português (PT) (49.49 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/pt/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_pt.pdf)

română (RO) (73.75 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/ro/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (59.8 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/sk/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (59.24 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/sl/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (44.56 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/fi/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (43.89 KB - PDF)

**First published:**

29/04/2013

**Last updated:**

23/10/2024

[View](/sv/documents/all-authorised-presentations/memantine-lek-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Memantine LEK Active substance memantine hydrochloride International non-proprietary name (INN) or common name memantine Therapeutic area (MeSH) Alzheimer Disease Anatomical therapeutic chemical (ATC) code N06DX01

### Pharmacotherapeutic group

- Psychoanaleptics
- Other anti-dementia drugs

### Therapeutic indication

Treatment of patients with moderate to severe Alzheimer's disease.

## Authorisation details

EMA product number EMEA/H/C/002630

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Pharmathen S.A.

6, Dervenakion str.

Opinion adopted 21/02/2013 Marketing authorisation issued 21/04/2013 Withdrawal of marketing authorisation 06/09/2024 Revision 5

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Memantine LEK : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (293.87 KB - PDF)

**First published:** 16/08/2013

**Last updated:** 23/10/2024

[View](/en/documents/procedural-steps-after/memantine-lek-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Memantine LEK : EPAR - Public assessment report

Adopted

Reference Number: EMA/227468/2013

English (EN) (818.67 KB - PDF)

**First published:** 29/04/2013

**Last updated:** 23/10/2024

[View](/en/documents/assessment-report/memantine-lek-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Memantine LEK

Adopted

Reference Number: EMA/CHMP/82409/2013

English (EN) (117.26 KB - PDF)

**First published:** 25/02/2013

**Last updated:** 23/10/2024

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-memantine-lek_en.pdf)

**This page was last updated on** 23/10/2024

## Share this page

[Back to top](#main-content)